Humalog®

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

HUMALOG® (insulin lispro) 200 Units/mL: Administration

Humalog 200 units/mL is available as a 3 mL KwikPen for subcutaneous use.

Detailed Information

Administer the dose of IL-200 within 15 minutes before a meal or immediately after a meal by SC injection into the abdominal wall, thigh, upper arm, or buttocks.1

IL-200 is available only as a 3 mL Pen for SC use.1

Do NOT transfer IL-200 from the Pen to a syringe as the markings on the insulin syringe will not measure the dose correctly and can result in overdosage and severe hypoglycemia.1

Do NOT administer IL-200 using a CSII (eg, insulin pump).1

Do NOT administer IL-200 by IV infusion.1

Do NOT mix IL-200 with any other insulins.1

Enclosed Prescribing Information

HUMALOG® (insulin lispro injection), for subcutaneous or intravenous use, Lilly

Reference

1. Humalog [package insert]. Indianapolis, IN: Eli Lilly and Company; 2019.

Glossary

CSII = continuous subcutaneous insulin infusion

IL-200 = Humalog® (insulin lispro injection) 200 units/mL

IV = intravenous

Pen = KwikPen®

SC = subcutaneous

Date of Last Review: December 13, 2019

Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon - Fri, 8am - 7pm ET

Or you can

Ask us a question Chat with us

Submit a Request

Visit Us @LillyMedical